Skip to content

15-Panel Fentanyl, Norfentanyl & EDDP Rapid Drug Test Cup – 120 mL | AMP, BAR, BUP, BZO, COC, EDDP, FEN, MDMA, MET, MTD, NFYL, OPI, OXY, PCP & THC15 Panel Drug Test Cup Detects Fentanyl, Nor Fentanyl & EDDP, CLIA Waived- Clearance! As low as $1.49

In Stock

$6.99$3.35/each

Buy More, Save More
Quantity
1

Description

15 DRUG PANELS • FENTANYL, NORFENTANYL & EDDP • 120 mL

15-Panel Fentanyl, Norfentanyl & EDDP Rapid Drug Test Cup

Advanced preliminary urine drug screening with dedicated fentanyl, norfentanyl and methadone-metabolite panels.

This self-contained 120 mL urine drug test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, EDDP, fentanyl, MDMA, methamphetamine, methadone, norfentanyl, opiates, oxycodone, phencyclidine and marijuana.

Separate FEN, NFYL, MTD and EDDP panels provide broader fentanyl- and methadone-related screening than parent-drug panels alone. Collection, temperature verification and preliminary testing take place in one integrated cup, with results available in approximately five minutes.

Product Highlights

Fifteen-Drug Screening Screens for AMP, BAR, BUP, BZO, COC, EDDP, FEN, MDMA, MET, MTD, NFYL, OPI, OXY, PCP and THC.
Fentanyl Screening Includes a dedicated FEN panel at the manufacturer-listed 1 ng/mL cutoff.
Norfentanyl Screening Includes a separate NFYL panel at the listed 5 ng/mL cutoff.
EDDP Screening Screens for the primary methadone metabolite at the listed 300 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, FEN, NFYL, MTD, EDDP, OPI and OXY panels.
Results in 5 Minutes Provides clear preliminary results for efficient onsite screening.
One-Step Testing Collection and preliminary screening are completed using one device.
Large 120 mL Capacity Provides ample specimen capacity for convenient urine collection.
Leak-Resistant Screw Lid Secure closure helps reduce leakage, spills and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Durable Design Fully integrated construction supports secure handling in professional testing workflows.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Fifteen Drug Panels with Fentanyl, Norfentanyl and EDDP Screening A comprehensive solution for healthcare facilities, treatment programs, rehabilitation centers, collection sites, occupational health clinics and authorized workplace-screening programs.

Drug Panels and Cutoff Levels

Review the fifteen drug categories and manufacturer-listed screening cutoff levels included in this configuration.

TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF
AMP   AMP   AMP   AMP   AMP
AMP   AMP   AMP   AMP   AMP
 Amphetamines 1–2 Days • 500 ng/mL
BAR   BAR   BAR   BAR   BAR
BAR   BAR   BAR   BAR   BAR
 Barbiturates 1–2 Days • 300 ng/mL
BUP   BUP   BUP   BUP   BUP
BUP   BUP   BUP   BUP   BUP
 Buprenorphine 2–6 Days • 10 ng/mL
BZO   BZO   BZO   BZO   BZO
BZO   BZO   BZO   BZO   BZO
 Benzodiazepines 1–2 Days • 300 ng/mL
COC   COC   COC   COC   COC
COC   COC   COC   COC   COC
 Cocaine 2–4 Days • 150 ng/mL
EDDP   EDDP   EDDP   EDDP
EDDP   EDDP   EDDP   EDDP
 EDDP / Methadone Metabolite 3–4 Days • 300 ng/mL
FEN   FEN   FEN   FEN   FEN
FEN   FEN   FEN   FEN   FEN
 Fentanyl 2–3 Days • 1 ng/mL
MDMA   MDMA   MDMA   MDMA
MDMA   MDMA   MDMA   MDMA
 MDMA / Ecstasy 2–4 Days • 500 ng/mL
MET   MET   MET   MET   MET
MET   MET   MET   MET   MET
 Methamphetamine 2–4 Days • 500 ng/mL
MTD   MTD   MTD   MTD   MTD
MTD   MTD   MTD   MTD   MTD
 Methadone 1–3 Days • 300 ng/mL
NFYL   NFYL   NFYL   NFYL
NFYL   NFYL   NFYL   NFYL
 Norfentanyl 3–4 Days • 5 ng/mL
OPI   OPI   OPI   OPI   OPI
OPI   OPI   OPI   OPI   OPI
 Morphine / Opiates 2–3 Days • 300 ng/mL
OXY   OXY   OXY   OXY   OXY
OXY   OXY   OXY   OXY   OXY
 Oxycodone 1–3 Days • 100 ng/mL
PCP   PCP   PCP   PCP   PCP
PCP   PCP   PCP   PCP   PCP
 Phencyclidine 7–14 Days • 25 ng/mL
THC   THC   THC   THC   THC
THC   THC   THC   THC   THC
 Marijuana 5+ Days • 50 ng/mL
Please Note: Detection times vary from person to person and may be affected by dosage, frequency of use, metabolism, hydration, body composition and specimen concentration. Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions.
Fentanyl and Norfentanyl Screening Fentanyl is the parent drug, while norfentanyl is a primary metabolite formed after fentanyl is processed by the body. Including separate FEN and NFYL panels may support broader preliminary screening across different stages of fentanyl exposure. Each panel must be interpreted independently according to the package insert.
Why EDDP Screening Is Included EDDP is a primary metabolite of methadone. Using separate MTD and EDDP panels may provide additional information in treatment, rehabilitation and pain-management workflows because the parent drug and its metabolite are screened independently.
Expanded Opioid-Related Coverage Separate BUP, FEN, NFYL, MTD, EDDP, OPI and OXY panels provide broader preliminary screening than a traditional opiate panel alone. A negative result on one opioid-related panel does not determine the result of another panel.

How to Use the 15-Panel Fentanyl, Norfentanyl & EDDP Rapid Drug Test Cup

Understanding the 15-Panel Fentanyl, Norfentanyl & EDDP Rapid Drug Test Cup Results

Product Dimensions and Specifications

15-Panel Fentanyl, Norfentanyl & EDDP Rapid Drug Test Cup
Drug Panels AMP, BAR, BUP, BZO, COC, EDDP, FEN, MDMA, MET, MTD, NFYL, OPI, OXY, PCP and THC
Fentanyl Cutoff FEN/1
Norfentanyl Cutoff NFYL/5
Methadone Cutoff MTD/300
EDDP Cutoff EDDP/300
Opiate Cutoff OPI/300
Oxycodone Cutoff OXY/100
Result Time Approximately 5 minutes
Capacity 120 mL
Height 3.25 inches
Width 2 inches
Lid Width 2.63 inches
Approximate Weight 0.18 lb

CLIA Waived and FDA 510(k) Cleared

Where this exact 15-panel configuration is labeled CLIA Waived and FDA 510(k) Cleared, it may be used for the intended purposes identified in the manufacturer’s labeling and in eligible point-of-care settings operating under a CLIA Certificate of Waiver.

What CLIA Waived Means The test is categorized as simple to perform and may be used by eligible sites holding a CLIA Certificate of Waiver when the manufacturer’s instructions are followed exactly.
What FDA 510(k) Cleared Means The device has completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.

Depending on the exact labeling and applicable requirements, this test cup may be suitable for physician offices, healthcare facilities, rehabilitation centers, addiction-treatment programs, pain-management settings, occupational health clinics, collection sites, probation and correctional programs and qualifying workplace-screening programs.

Regulatory Notice: FDA clearance and CLIA-waived status are separate designations and may vary by exact cup configuration or individual assay. Confirm the status of the exact product before advertising, purchasing or use.

Frequently Asked Questions

1. What substances does this 15-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, EDDP, fentanyl, MDMA, methamphetamine, methadone, norfentanyl, opiates, oxycodone, phencyclidine and marijuana.
2. What is the difference between fentanyl and norfentanyl? Fentanyl is the parent drug. Norfentanyl is a primary metabolite produced as fentanyl is processed by the body. Separate panels provide preliminary screening for each listed analyte.
3. Why are methadone and EDDP tested separately? Methadone is the parent medication, while EDDP is a primary methadone metabolite. Separate panels may provide broader information than screening for the parent drug alone.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Do not interpret results after ten minutes or outside the package insert’s stated reading window.
5. Does the temperature strip detect dilution or adulteration? No. The strip measures specimen temperature shortly after collection. Evaluation for dilution or adulteration requires appropriate specimen-validity testing.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, treatment or legal decisions are made.
Fifteen Drug Panels. Fentanyl and Norfentanyl Screening. Methadone and EDDP Coverage. Simplify comprehensive preliminary urine drug screening with a self-contained 120 mL cup designed for broad coverage, secure collection and easy visual interpretation.
Order 15-Panel Drug Test Cups Today

Shipping & Delivery

  • All orders will be shipped the same day if placed before 3:00 PM EST.
  • Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.

Why order from us

  • CLIA-waived screening supplies for qualified lab and point-of-care workflows.
  • Same-day shipping on orders placed before 3:00 PM EST.
  • Volume and bulk pricing available — contact us for recurring supply.